Skip to main content
. 2019 May 23;145(7):597–608. doi: 10.1001/jamaoto.2019.0821

Table 4. Data on Participants With Minimal Clinically Significant Change Between Baseline and 18 Months by Treatment Group.

Scale Treatment Group, No./Total No. (%) [95% CI]
SoC (n = 37) Partial TRT (n = 40) TRT (n = 34) Total (N = 111)
Tinnitus Questionnaire (7-point difference) 29/37 (78.4) [65.1-91.6] 33/40 (82.5) [70.7-94.3] 24/34 (70.6) [55.3-86.9] 86/111 (77.5) [60.7-86.2]
Tinnitus Functional Index (13-point difference) 15/37 (40.5) [24.7-56.4] 21/40 (52.5) [37.0-68.0] 16/34 (47.1) [30.3-63.8] 52/111 (46.8) [37.6-56.1]
Tinnitus Handicap Inventory (7-point difference) 20/37 (54.1) [38.0-70.1] 25/40 (62.5) [47.5-77.5] 18/34 (52.9) [36.2-69.7] 63/111 (56.8) [47.5-66.0]
Visual analog scale (2-point difference) 16/33(48.5) [31.4-65.5] 18/31 (58.1) [40.7-75.4] 11/29 (37.9) [20.3-55.6] 45/93 (48.4) [38.2-58.5]

Abbreviations: SoC, standard of care; TRT, tinnitus retraining therapy.